Ritonavir
Showing 1 - 25 of 1,309
COVID-19 Respiratory Infection Trial in Changchun (GST-HG171/ritonavir, ritonavir)
Active, not recruiting
- COVID-19 Respiratory Infection
- GST-HG171/ritonavir
- ritonavir
-
Changchun, Jilin, ChinaThe first hospital of Jilin University
Oct 10, 2023
Healthy Participant Trial in Changchun (GST-HG171/Ritonavir, Itraconazole)
Completed
- Healthy Participant
-
Changchun, Jilin, ChinaThe first hospital of Jilin University
Oct 11, 2023
Healthy Volunteers Trial in Jinan (Cohort 1: SIM0417/ritonavir and itraconazole, Cohort 2: SIM0417/ritonavir and rifampicin,
Active, not recruiting
- Healthy Volunteers
- Cohort 1: SIM0417/ritonavir and itraconazole
- +2 more
-
Jinan, Shandong, ChinaShandong First Medical University
Jan 13, 2023
Biological Availability Trial (Nirmatrelvir/ ritonavir, Nirmatrelvir/Ritonavir, Nirmatrelvir/ritonavir)
Not yet recruiting
- Biological Availability
- Nirmatrelvir/ ritonavir
- +2 more
- (no location specified)
Sep 14, 2022
Elder Trial in Jinan (SIM0417/Ritonavir)
Recruiting
- Elder
-
Jinan, Shandong, ChinaShandong First Medical University
Apr 20, 2023
Omicron Variant of COVID-19 Trial in Wenzhou (Nirmatrelvir/Ritonavir)
Completed
- Omicron Variant of COVID-19
-
Wenzhou, Zhejiang, ChinaXiangao Jiang
Apr 12, 2023
Renal Impairment, Hepatic Impairment Trial in Jinan (SIM0417 600 mg; Ritonavir100 mg, SIM0417 375 mg; Ritonavir100 mg, SIM0417
Not yet recruiting
- Renal Impairment
- Hepatic Impairment
- SIM0417 600 mg; Ritonavir100 mg
- +2 more
-
Jinan, Shandong, ChinaShandong Provincial Qianfoshan Hospital
Feb 7, 2023
Pharmacokinetics, Healthy Volunteers Trial in Brussels (Rosuvastatin, Nirmatrelvir/ritonavir)
Not yet recruiting
- Pharmacokinetics
- Healthy Volunteers
-
Brussels, Bruxelles-capitale, RĂ©gion DE, BelgiumBrussels Clinical Research Unit
Jun 1, 2023
Post-COVID-19 Syndrome, Long COVID, Long Covid19 Trial in Stockholm (Nirmatrelvir/ritonavir, Placebo/ritonavir)
Not yet recruiting
- Post-COVID-19 Syndrome
- +9 more
- Nirmatrelvir/ritonavir
- Placebo/ritonavir
-
Stockholm, SwedenKarolinska Institutet
Apr 20, 2023
Drug Interaction Trial in Ile-Ife (Nitazoxanide, "Nitazoxanide" and "atazanavir/ritonavir" separately)
Active, not recruiting
- Drug Interaction
- Nitazoxanide
- "Nitazoxanide" and "atazanavir/ritonavir" separately
-
Ile-Ife, Osun, NigeriaObafemi Awolowo University
Jan 8, 2023
Cardiac Surgery Trial in Beijing (Nirmatrelvir/ritonavir, Ursodeoxycholic acid)
Recruiting
- Cardiac Surgery
- Nirmatrelvir/ritonavir
- Ursodeoxycholic acid
-
Beijing, Beijing, ChinaFuwai Hospital
Jan 18, 2023
Nirmatrelvir-ritonavir in Hospitalized Patients
Recruiting
- Hospitalized Patients
-
Hangzhou, Zhejiang, ChinaChangcheng Shi
Feb 26, 2023
Drug-drug Interaction Trial in Tempe (PBI-200 Tablet, Ritonavir Oral Tablet, Cobicistat Oral Tablet)
Completed
- Drug-drug Interaction
- PBI-200 Tablet
- +2 more
-
Tempe, ArizonaCelerion, Inc.
Jan 11, 2023
Learn About the COVID-19 Prescribed Paxlovid in Morocco
Not yet recruiting
- COVID-19 Drug Treatment
- (no location specified)
Aug 15, 2023
Healthcare Resource Use Among COVID-19 Patients Receiving
Not yet recruiting
- Covid-19
- nirmatrelvir, ritonavir
-
Riyadh, Saudi ArabiaSaudi Arabia
Aug 25, 2023
Prostate Cancer, Prostate Cancer Metastatic, Prostate Adenocarcinoma Trial (Relugolix Pill, Ritonavir, Itraconazole)
Not yet recruiting
- Prostate Cancer
- +2 more
- Relugolix Pill
- +2 more
- (no location specified)
Dec 23, 2022
High-Grade Anal Intraepithelial Neoplasia Trial in Madison (Lopinavir / Ritonavir)
Not yet recruiting
- High-Grade Anal Intraepithelial Neoplasia
- Lopinavir / Ritonavir
-
Madison, WisconsinUW Digestive Health Center Anoscopy Clinic
Jan 12, 2023
Bioavailability Trial in New Haven (PF-07321332/ritonavir)
Completed
- Bioavailability
-
New Haven, ConnecticutNew Haven Clinical Research Unit
Jun 28, 2022
COVID-19 Pneumonia Trial (GST-HG171/Ritonavir, Placebo)
Not yet recruiting
- COVID-19 Pneumonia
- GST-HG171/Ritonavir
- Placebo
- (no location specified)
Dec 18, 2022
CKD Patients Treated With Nirmatrelvir-ritonavir
Recruiting
- COVID-19
- +2 more
-
Shatin, New Territories, Hong KongPrince of Wales Hospital, Chinese University of Hong Kong
Nov 21, 2022